JP Patent
JP6827962B2 — 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬
Assigned to ラボラトリオス レオン ファーマ エスエー · Expires 2021-02-10 · 5y expired
What this patent protects
Patent listed against Slynd.
Drugs covered by this patent
- Slynd (DROSPIRENONE) · Exeltis Usa Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.